Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3946)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 5, 2025 (publication date) through May 9, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Ismail A, Amer MS, Tawheed A. Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions. World J Gastrointest Pharmacol Ther 2025; 16(3): 107148 [PMID: 40937289 DOI: 10.4292/wjgpt.v16.i3.107148] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Ismail A, Amer MS, Tawheed A. Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions. World J Gastrointest Pharmacol Ther 2025; 16(3): 107148 [PMID: 40937289 DOI: 10.4292/wjgpt.v16.i3.107148] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i3/107148.htm |
| Number | Citing Articles |
| 1 |
Krishna Bonga, Milan Padhan. Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control. Rambam Maimonides Medical Journal 2026; 17(1): e0006 doi: 10.5041/RMMJ.10565
|
| 2 |
Riad Mohammed Abdelrahman, Taha Hussein Musa, Ismail Adam Arbab, Eltieb Omer Ahmed, Sahar Ibrahim Gasmallah, Mohammed Jalal, Wafaa Ramadan Ahmed, Khalid Hamid Fadul. Mapping Global Research on Adverse Effects of GLP-1 Receptor Agonists (2006-2025): A Scopus-Based Bibliometric and Thematic Analysis. INQUIRY: The Journal of Health Care Organization, Provision, and Financing 2026; 63 doi: 10.1177/00469580261441498
|
| 3 |
Nicole Ann Tesoro, Frederick Berro Rivera, Nathan Ross B. Bantayan, John Vincent Magalong, Romaine Tomada, Maria Antonia Wong, Gabriel Tangco, Polyn Luz Pine, Jasvin Kurundrayil Manha, Elora Shyama Tanni, Christine Lin, Sung-Ki Lee, Kyla Lara-Breitinger, Martha Gulati. Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction–associated steatotic liver disease. American Journal of Preventive Cardiology 2026; : 101623 doi: 10.1016/j.ajpc.2026.101623
|
| 4 |
Riad Mohammed Abdelrahman, Taha Hussein Musa, Ismail Adam Arbab, Eltieb Omer Ahmed, Sahar Ibrahim Gasmallah, Mohammed Jalal, Chiamaka Linda Mgbechidinma, Wafaa Ramadan Ahmed. Adverse effects of GLP-1 receptor agonists: Clinical Implications, regulatory perspectives, and future directions. Obesity Medicine 2026; 61: 100699 doi: 10.1016/j.obmed.2026.100699
|
| 5 |
Hanadi A. Hafth, Nawras A. Alwan, Eman Aboud Al-Masoudi. The effect of liraglutide on overweight and streptozotocin-induced diabetic male rats. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2026; 22(2): 159 doi: 10.22141/2224-0721.22.2.2026.1691
|